Results 161 to 170 of about 8,594,077 (317)
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero +8 more
wiley +1 more source
Correction: Carotenuto et al. <i>Xenopus laevis</i> (Daudin, 1802) as a Model Organism for Bioscience: A Historic Review and Perspective. <i>Biology</i> 2023, <i>12</i>, 890. [PDF]
Carotenuto R +3 more
europepmc +1 more source
The big, the bad, and the beautiful: Biology of the world's largest flowers [PDF]
Lachezar A. Nikolov, Charles C. Davis
openalex +1 more source
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
The Powerful Impact of Interdisciplinary Collaboration Between Societies. [PDF]
Frevert CW, Schaefer L, Hewitt SM.
europepmc +1 more source
Vestigial rides a fat/dachsous wave in wing development. [PDF]
PLoS Biology Editors
doaj +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source

